| DRUGCOAT SERIES | MONOGRAPHS | PHYSICAL FORM | DISSOLUTION PROPERTIES |
| DRUGCOAT RL 100 | USP/NF: Ammonio Methacrylate Copolymer, Type A Ph. Eur.: Ammonio Methacrylate Copolymer, Type A |
Granules | pH-independent swelling |
| DRUGCOAT RL PO | Powder | ||
| DRUGCOAT RL 12.5 | Organic Solution 12.5% | ||
| DRUGCOAT RS 100 | USP/NF: Ammonio Methacrylate Copolymer, Type B Ph. Eur.: Ammonio Methacrylate Copolymer, Type B |
Granules | |
| DRUGCOAT RS PO | Powder | ||
| DRUGCOAT RS 12.5 | Organic Solution 12.5% | ||
| DRUGCOAT NE 30D | USP/NF: Ethyl Acrylate And Methyl Methacrylate Copolymer Dispersion Ph. Eur.: Polyacrylate Dispersion 30% |
Aqueous Dispersion 30% |
Our company revolves around giving maximum to the two pillars that lay the foundation for our business: People and Product. Through constant R&D and innovation, the company plans to build a better future without compromising the quality and safety to reach a higher level of excellence in healthcare facilities.
Let’s create opportunities together